AREVA Med Launches Production of Lead-212 at New Facility
21 nov. 2013 16h53 HE
|
AREVA Med
PARIS, Nov. 21, 2013 (GLOBE NEWSWIRE) -- AREVA Med inaugurated today the Maurice Tubiana Facility located at Bessines-sur-Gartempe, France (Limousin region). After receiving the administrative...
AREVA Med Presents Pharmacokinetics Data From Phase 1 Clinical Trial at SNMMI
17 mai 2013 09h41 HE
|
AREVA Med
BETHESDA, Md., May 17, 2013 (GLOBE NEWSWIRE) -- AREVA Med, an AREVA subsidiary specializing in the development of new innovative therapies to fight cancer, announced today that it will present...
![Roche logo](http://www.globenewswire.com/fr/Attachment/LogoDisplay/214239?filename=214239.jpg&size=2)
Roche and AREVA Med Join Forces in the Fight Against Cancer and Create a Novel Radio-Immunotherapy
27 juil. 2012 07h59 HE
|
AREVA Med
BASEL, Switzerland, PARIS and BETHESDA, Md., July 27, 2012 (GLOBE NEWSWIRE) -- Roche (SIX:RO; ROG) (OTCQX:RHHBY) and AREVA Med, a subsidiary of AREVA, announced today that they have entered into a...
AREVA Med's Clinical Trial Now Enrolling Patients at UAB Affiliates
03 mai 2012 08h00 HE
|
AREVA Med
BETHESDA, Md., May 3, 2012 (GLOBE NEWSWIRE) -- AREVA Med announced that University of Alabama at Birmingham's (UAB) Cancer Center Network affiliates are now enrolling patients for the Phase I clinical...
AREVA Med Acquires Macrocyclics, Inc.
20 oct. 2011 11h59 HE
|
AREVA Med
BETHESDA, Md., Oct. 20, 2011 (GLOBE NEWSWIRE) -- AREVA announced today that its nuclear medicine subsidiary, AREVA Med, has acquired Macrocyclics, Inc.
AREVA Med has developed innovative methods for...